When light cannabis (CBD products) became unexpectedly available in Italy in 2017, prescription sales of anxiolytics, sedatives, opioids, antidepressants, and antipsychotics significantly declined.
Health economists, drug policy analysts, medical cannabis advocates and skeptics
CBD availability reduced prescriptions across five drug categories including opioids
What the researchers found
Using the staggered rollout of light cannabis shops across Italian provinces, the study documented significant substitution effects between CBD products and five prescription drug categories: anxiolytics, sedatives, opioids, antidepressants, and antipsychotics.
Why it matters
This provides some of the strongest economic evidence that legal access to CBD products leads people to substitute away from prescription medications, with implications for drug policy and healthcare costs.
The numbers in context
Significant substitution effects documented for five drug categories: anxiolytics, sedatives, opioids, antidepressants, and antipsychotics. The study used high-frequency data across all Italian provinces.
How the study worked
Natural experiment exploiting Italy's unintended 2017 liberalization of CBD-based "light cannabis." High-frequency prescription drug sales data analyzed using the staggered local availability of light cannabis across Italian provinces as a quasi-experimental design.
What this study cannot tell us
Cannot identify individual-level substitution; ecological design using province-level data; cannot determine whether patients benefited from switching to CBD; unregulated CBD products may have variable quality.
How to read the evidence
Clever natural experiment design using staggered rollout, but ecological data cannot confirm individual-level substitution or health outcomes.
When this study was published
Published in 2020.
The bigger picture
The pattern of prescription substitution suggests people may be self-treating symptoms of anxiety, pain, sleep disorders, and mood conditions with CBD products, whether or not clinical evidence supports those uses.
Questions still open
- Are patients who switched to CBD experiencing better or worse outcomes? Could regulated CBD access reduce healthcare costs if substitution effects are confirmed?
Common questions
What is "light cannabis" in Italy?
Does this mean CBD is as effective as prescription medications?
Read the original research
Do-It-Yourself medicine? The impact of light cannabis liberalization on prescription drugs.
Journal of health economics, 74, 102371
Citation
Carrieri, Vincenzo; Madio, Leonardo; Principe, Francesco. (2020). Do-It-Yourself medicine? The impact of light cannabis liberalization on prescription drugs.. Journal of health economics, 74, 102371. https://doi.org/10.1016/j.jhealeco.2020.102371
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk